UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy

International journal of molecular sciences, 2017-02, Vol.18 (2), p.405-405

2017

Volltextzugriff (PDF)

Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever

Liver international, 2014-07, Vol.34 (6), p.834-843

2014

Volltextzugriff (PDF)

The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance

International journal of molecular sciences, 2022-12, Vol.24 (1), p.245

2022

Volltextzugriff (PDF)

Determination and Characterization of Tetraspanin-Associated Phosphoinositide-4 Kinases in Primary and Neoplastic Liver Cells

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1376, p.203

2016

Volltextzugriff (PDF)

CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression

Gut, 2018-02, Vol.67 (2), p.348-361

2018

Volltextzugriff (PDF)

DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer

Cancer research (Chicago, Ill.), 2021-06, Vol.81 (11), p.2861-2873

2021

Volltextzugriff (PDF)

Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2008-07, Vol.135 (1), p.244-256.e1

2008

Volltextzugriff (PDF)

The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma

Fibrogenesis & tissue repair, 2013-09, Vol.6 (1), p.17-17, Article 17

2013

Volltextzugriff (PDF)

Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo

Cancer letters, 2013-06, Vol.333 (2), p.244-252

2013

Volltextzugriff (PDF)

The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis

Molecular cytogenetics, 2021-07, Vol.14 (1), p.33-10, Article 33

2021

Volltextzugriff (PDF)

The metastatic process: methodological advances and pharmacological challenges

Current medicinal chemistry, 2009-05, Vol.16 (14), p.1704-1717

2009

Volltextzugriff (PDF)

CD63 Tetraspanin Is a Negative Driver of Epithelial-to-Mesenchymal Transition in Human Melanoma Cells

Journal of investigative dermatology, 2014-12, Vol.134 (12), p.2947-2956

2014

Volltextzugriff (PDF)

Tetraspanin CD81 is linked to ERK MAPKinase signaling by Shc in liver tumor cells

Oncogene, 2004-02, Vol.23 (8), p.1566-1574

2004

Volltextzugriff (PDF)

Binding of Hepatitis C Virus Envelope Protein E2 to CD81 Up-regulates Matrix Metalloproteinase-2 in Human Hepatic Stellate Cells

The Journal of biological chemistry, 2005-03, Vol.280 (12), p.11329-11339

2005

Volltextzugriff (PDF)

Defective mitosis-linked DNA damage response and chromosomal instability in liver cancer

Biochimica et biophysica acta. Reviews on cancer, 2019-08, Vol.1872 (1), p.60-65

2019

Volltextzugriff (PDF)

Farnesyltransferase Inhibitor, ABT-100, Is a Potent Liver Cancer Chemopreventive Agent

Clinical cancer research, 2005-06, Vol.11 (11), p.4266-4274

2005

Volltextzugriff (PDF)

FRI-502 KDM2A chromatin regulator constrains senescence program and immunoresponse in liver cancer

Journal of hepatology, 2024-06, Vol.80, p.S428-S428

2024

Volltextzugriff (PDF)

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Journal of controlled release, 2017-12, Vol.268, p.184-197

2017

Volltextzugriff (PDF)

DNA damage response protein checkpoint kinase 2 (CHK2) links chromosomal instability to cellular metabolism in hepatocellular carcinoma (HCC)

Journal of hepatology, 2020-08, Vol.73, p.S639-S640

2020

Volltextzugriff (PDF)

FRI492 - DNA damage response protein checkpoint kinase 2 (CHK2) links chromosomal instability to cellular metabolism in hepatocellular carcinoma (HCC)

Journal of hepatology, 2020-08, Vol.73, p.S639-S640

2020

Volltextzugriff (PDF)

THU-447-DNA damage response CHK2 activates senescence cellular program and supports oxidative metabolism to drive hepatocellular carcinoma development

Journal of hepatology, 2019-04, Vol.70 (1), p.e355-e355

2019

Volltextzugriff (PDF)

Tetraspanin-enriched microdomains and hepatocellular carcinoma progression

Cancer letters, 2014-08, Vol.351 (1), p.23-29

2014

Volltextzugriff (PDF)

Growth Inhibition by the Farnesyltransferase Inhibitor FTI-277 Involves Bcl-2 Expression and Defective Association with Raf-1 in Liver Cancer Cell Lines

Molecular pharmacology, 2003-01, Vol.63 (1), p.159-166

2003

Volltextzugriff (PDF)

Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells

Journal of chemotherapy (Florence), 2013-10, Vol.25 (5), p.292-297

2013

Volltextzugriff (PDF)

Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tail recruitment of protein kinase A

Journal of cell science, 2004-03, Vol.117 (Pt 7), p.1235-1246

2004

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(58)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Humans
(32)
Biological And Medical Sciences
(21)
Medical Sciences
(18)
Gastroenterology & Hepatology
(13)
Female
(10)
Male
(10)
Oncology
(10)
Tumors
(9)
Animals
(8)
Biochemistry & Molecular Biology
(8)
Cells, Cultured
(8)
Hepatocellular Carcinoma
(8)
Pharmacology. Drug Treatments
(8)
Aged
(7)
Cell Line, Tumor
(7)
Gastroenterology. Liver. Pancreas. Abdomen
(7)
Liver Cancer
(7)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy

Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever

The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance

Determination and Characterization of Tetraspanin-Associated Phosphoinositide-4 Kinases in Primary and Neoplastic Liver Cells

CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression

DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer

Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular Carcinoma

The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma

Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo

The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis

The metastatic process: methodological advances and pharmacological challenges

CD63 Tetraspanin Is a Negative Driver of Epithelial-to-Mesenchymal Transition in Human Melanoma Cells

Tetraspanin CD81 is linked to ERK MAPKinase signaling by Shc in liver tumor cells

Binding of Hepatitis C Virus Envelope Protein E2 to CD81 Up-regulates Matrix Metalloproteinase-2 in Human Hepatic Stellate Cells

Defective mitosis-linked DNA damage response and chromosomal instability in liver cancer

Farnesyltransferase Inhibitor, ABT-100, Is a Potent Liver Cancer Chemopreventive Agent

FRI-502 KDM2A chromatin regulator constrains senescence program and immunoresponse in liver cancer

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

DNA damage response protein checkpoint kinase 2 (CHK2) links chromosomal instability to cellular metabolism in hepatocellular carcinoma (HCC)

FRI492 - DNA damage response protein checkpoint kinase 2 (CHK2) links chromosomal instability to cellular metabolism in hepatocellular carcinoma (HCC)

THU-447-DNA damage response CHK2 activates senescence cellular program and supports oxidative metabolism to drive hepatocellular carcinoma development

Tetraspanin-enriched microdomains and hepatocellular carcinoma progression

Growth Inhibition by the Farnesyltransferase Inhibitor FTI-277 Involves Bcl-2 Expression and Defective Association with Raf-1 in Liver Cancer Cell Lines

Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells

Increased phosphorylation of AKAP by inhibition of phosphatidylinositol 3-kinase enhances human sperm motility through tail recruitment of protein kinase A

Suchergebnisse filtern